Evidence map›Paper›PMID 42500326›Full record

ArticleRadiology advances2026

AI-accelerated 3D gradient echo versus ultrashort echo time MRI for lung nodule detection and measurement.

Alexander W Marka, Kilian Weiss, Hannah Rosenkranz, Bernadette Scherer, Lisa Adams, Keno Bressem, Nicolas Lenhart, Tristan Lemke, Florian T Gassert, Marcus R Makowski and 6 more

Abstract read
In one paragraph

Article in Radiology advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Alexander W MarkaInstitute for Diagnostic and Interventional Radiology, School of Medicine and Health, TUM Klinikum, Technical University of Munich (TUM), Munich 81675, Germany.ORCID https://orcid.org/0000-0002-2111-8177
Kilian WeissPhilips GmbH Market DACH, Hamburg 22335, Germany.
Hannah RosenkranzInstitute for Diagnostic and Interventional Radiology, School of Medicine and Health, TUM Klinikum, Technical University of Munich (TUM), Munich 81675, Germany.
Bernadette SchererInstitute for Diagnostic and Interventional Radiology, School of Medicine and Health, TUM Klinikum, Technical University of Munich (TUM), Munich 81675, Germany.
Lisa AdamsInstitute for Diagnostic and Interventional Radiology, School of Medicine and Health, TUM Klinikum, Technical University of Munich (TUM), Munich 81675, Germany.
Keno BressemInstitute for Diagnostic and Interventional Radiology, School of Medicine and Health, TUM Klinikum, Technical University of Munich (TUM), Munich 81675, Germany.ORCID https://orcid.org/0000-0001-9249-8624
Nicolas LenhartInstitute for Diagnostic and Interventional Radiology, School of Medicine and Health, TUM Klinikum, Technical University of Munich (TUM), Munich 81675, Germany.
Tristan LemkeInstitute for Diagnostic and Interventional Radiology, School of Medicine and Health, TUM Klinikum, Technical University of Munich (TUM), Munich 81675, Germany.
Florian T GassertInstitute for Diagnostic and Interventional Radiology, School of Medicine and Health, TUM Klinikum, Technical University of Munich (TUM), Munich 81675, Germany.
Marcus R MakowskiInstitute for Diagnostic and Interventional Radiology, School of Medicine and Health, TUM Klinikum, Technical University of Munich (TUM), Munich 81675, Germany.ORCID https://orcid.org/0000-0002-1922-0826
Daniela PfeifferInstitute for Diagnostic and Interventional Radiology, School of Medicine and Health, TUM Klinikum, Technical University of Munich (TUM), Munich 81675, Germany.ORCID https://orcid.org/0000-0003-2002-8337
Gregor S ZimmermannDivision of Respiratory Medicine, Department of Internal Medicine I, School of Medicine and Health, Klinikum rechts der Isar, TUM University Hospital, Technical University of Munich, Munich 81675, Germany.
Seyer SafiDivision of Thoracic Surgery, Department of Surgery, School of Medicine and Health, TUM Klinikum, Technical University of Munich (TUM), Munich 81675, Germany.
Dimitrios C KarampinosInstitute for Diagnostic and Interventional Radiology, School of Medicine and Health, TUM Klinikum, Technical University of Munich (TUM), Munich 81675, Germany.
Markus GrafInstitute for Diagnostic and Interventional Radiology, School of Medicine and Health, TUM Klinikum, Technical University of Munich (TUM), Munich 81675, Germany.
Sebastian ZiegelmayerInstitute for Diagnostic and Interventional Radiology, School of Medicine and Health, TUM Klinikum, Technical University of Munich (TUM), Munich 81675, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Ultrashort echo time (UTE) sequences are widely used in pulmonary MRI due to favorable lung parenchyma signal but are limited by acquisition time and complex reconstruction. Purpose: To compare an AI-enhanced 3D gradient echo sequence with a UTE sequence for lung nodule detection and Lung-RADS classification, using CT as the reference standard. Materials and Methods: In this single-center observational study, patients with at least one CT-detected lung nodule underwent pulmonary MRI. MRI included a respiratory-gated AI-accelerated 3D gradient-echo sequence (CSAI-GRE) and a respiratory-gated 3D UTE sequence, both acquired with comparable scan times. Three radiologists independently assessed image quality, nodule detection, and Lung-RADS classification. CT served as the reference standard. Statistical analyses included paired tests for image quality, mixed-effects modeling for lesion-level detection, and Results: This study included 54 patients (mean age, 65 ± 12 years; 23 women [43%]) with 97 pulmonary nodules. Subjective image quality was higher for CSAI-GRE than UTE (mean score, 4.30 vs 3.91; Conclusion: CSAI-GRE and UTE enabled reliable pulmonary nodule detection. CSAI-GRE provided superior subjective image quality and slightly higher detection performance than UTE. However, the Lung-RADS reclassification rates suggest that MRI-based Lung-RADS categorization may not yet be sufficiently robust for routine clinical application.

Indexed as

CSAIlow-dose CTlungsMRInodulesUTE

Identifiers

PMID42500326
PMCPMC13399443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.